Partners Roberto Arena and Fernando Camarena were quoted in the El Economista article, “Falta claridad en estímulos fiscales para la frontera norte” about the Decree of Fiscal Incentives North Border Region, signed by President Andrés Manuel López Obrador.
Camarena stated that the reduction in the VAT rate and the ISR will be reflected in a reduction of collection; however, he added that the intent is that this reduction will be off-set once the increase in commercial and production activity is achieved in the cities where the measures will be applied.
Arena explained that the tax benefits provided in the decree will be valid for two years. This period will allow enough time to evaluate the impact of these measures and to consider whether they should be made permanent by law. Furthermore, Arena estimated that the positive effects of these measures may be seen in as little as six months
Camarena stated that the reduction in the VAT rate and the ISR will be reflected in a reduction of collection; however, he added that the intent is that this reduction will be off-set once the increase in commercial and production activity is achieved in the cities where the measures will be applied.
Arena explained that the tax benefits provided in the decree will be valid for two years. This period will allow enough time to evaluate the impact of these measures and to consider whether they should be made permanent by law. Furthermore, Arena estimated that the positive effects of these measures may be seen in as little as six months
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”